Image

Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies

Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

In this project, the investigators will realize an observational, prospective, multicentric and international clinical trial, to objectively compare patients with SSCC according to 3 arms of treatment:

  • Arm 1: Radiotherapy ± chemotherapy
  • Arm 2: Trans-oral Laser Microsurgery (TLM)
  • Arm 3: Trans-oral Robotic Surgery (TORS)

The main goal is to evaluate the efficacy of each treatment with four classes of outcomes:

  • The quality of life (QoL) before and after each treatment option, using validated questionnaires
  • Oncological outcomes
  • Functional outcomes
  • Economical Resources

The population will include cT1-T2 /cN0-N1/M0 supraglottic squamous cell carcinoma.

The primary outcome is a Clinical Dysphagia QoL evaluation assessed by the MD Anderson Dysphagia questionnaire. Secondary outcomes include others QoL evaluation, oncological and functional measures and cost parameters. The sample size needs to reach 36 patients per arm (total 108).

Eligibility

Inclusion Criteria:

  • Diagnosis of SSCC (with histological confirmation)
    • cT1-T2 / cN0-N1/ M0 according to 8th TNM classification (UICC/AJCC)
    • WITH a Multidisciplinary Tumor Board decision according to the NCCN or European guidelines
  • Diagnostic imaging (Head and neck and pulmonary CT or PET/CT, +/- IRM if needed)

    realized within 1 month before the study inclusion

  • ≥ 18 years old and able to provide an informed consent
  • ECOG/WHO performance status ≤ 2

Exclusion Criteria:

  • - Previous radiotherapy +/- chemotherapy treatment of the head and neck region
  • Previous history of head and neck cancer within 5 years
  • Prior invasive malignant disease unless disease-free for at least 5 years or more, with exception of non-melanoma skin cancer
  • Non-supraglottic or unknown primary site
  • Clinical and radiological signs of nodal extracapsular extension
  • Significant trismus (maximum inter-incisal opening ≤ 35 mm)
  • Pre-existing dysphagia not related to the cancer or the biopsy (from neurological disorders for example)
  • Unable or unwilling to complete Quality of Life questionnaires
  • Serious medical comorbidities or contraindication for surgery and/or radiation
  • Pregnancy and lactation

Study details
    Supraglottic Squamous Cell Carcinoma
    Early Stage (T1-T2
    N0-N1
    M0)

NCT05611515

Centre Hospitalier Universitaire UCLouvain Namur

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.